NZCR is at the forefront of early phase clinical research. Our focus on quality and innovation has resulted in many exciting medical breakthroughs. These news articles highlight current research projects and innovations at NZCR.
Home / About Us / About NZCR / News
NZCR CEO receives IQVIA Certificate of Achievement (2020)
Kiwis are being given an opportunity to take part in a trial of a potential new COVID-19 vaccine.
New Zealand is leading the world in a new era of exciting gene research with potential to cure genetic conditions in the future.
When two Stanford University graduates (who would eventually own the United States' biggest vaping company), wanted their prototype tested they came to Christchurch!
A trial conducted at CCST (NZCR) by Dr Martin de Bock, Paediatrician, Otago University researcher could have life changing outcomes for people living with Type 1 diabetes.
New Zealand Clinical Research (NZCR) provides state of the art research facilities and the expertise to conduct complex early phase clinical research in healthy participant and patient populations.